INTRODUCTION
-independent (autono-inhibitors KN-62 and KN-93 leads to cell cycle arrest mous) CaMK-II enzymatic activity, a barometer of in during G1 and S phase [1] [2] [3] [4] . These compounds act situ activated CaMK-II, was prevented by the same KN-by antagonizing CaM binding, a necessary step in the 93 concentrations that cause G1 phase arrest. KN-93 activity of this family of enzymes [5] . These findings caused the retinoblastoma protein pRB to become de-corroborate other reports that Ca 2/ and CaM are necesphosphorylated and the activity of both cdk2 and cdk4, sary for G1 progression in fibroblasts [6] [7] [8] [9] [10] [11] [12] .
two potential pRb kinases, to decrease. Neither the
There are six primary CaM kinases, which include activity of p42 MAP kinase , an early response G1 signaling
CaMK-I, II, III, and IV, myosin light-chain kinase, and molecule, nor the phosphorylation status or DNA-bindphosphorylase kinase [13, 14] . CaMK-I is monomeric, ing capability of the transcription factors serum reis primarily cytoplasmic, and is regulated through sponse factor and cAMP responsive element-binding stimulatory phosphorylations by other CaM kinases protein was altered during this G1 arrest. The protein [15] [16] [17] . CaMK-IV is also regulated by stimulatory levels of cyclin-dependent kinase 2 (cdk2) and cdk4
were unaffected during this G1 arrest and the total CaM kinases [18] , but is specific to neuronal and reprocellular levels of the cdk inhibitors p21 cip1 and p27 kip1 ductive cells [14] . CaMK-II [the (type II) multifuncwere not increased. Instead, the cdk4 activity de-tional Ca 2/ /CaM kinase] is encoded by four known creases resulting from KN-93 were the result of a 75% genes (a, b, g, and d) which give rise to over two dozen decrease in cyclin D1 levels. In contrast, cyclin A and CaMK-II subtypes, through alternative splicing [19- E levels were relatively constant. Cdk2 activity de-24]. CaMK-II is widely expressed [25] [26] [27] [28] [29] and is associ-prepared by sonication solubilized over 90% of the total CaMK-II 1, ATF-1 [43] . CaMK-IV has also been implicated to activity or pRb as measured by solution assays and immunoblots mediate Ca 2/ -dependent gene expression through SRF, (data not shown). the serum-response factor [44] . The Ca 2/ -dependent are decreased by CaM antagonists [9] . CaMK-II has ERK1/2 activities were measured in immunoprecipitates of sonicated whole-cell lysates, as previously described [29] . These kinases were been also shown to influence ubiquitin-mediated cyclin immunopurified from 50 mg of cellular protein by incubating for 2 h proteolysis in invertebrate and vertebrate embryos with 1 mg of purified mouse anti-cyclin D1 (Santa Cruz Biotechnology [47 -49] .
sc-246, Santa Cruz, CA); rabbit anti-cyclin E (Santa Cruz Biotechnol-
The intention of this study was to define the molecu-ogy sc-481); rabbit anti-cdk2 (Santa Cruz Biotechnology sc-163); goat lar basis for the G1 arrest caused by the CaMK-II in-anti-cdk4 (Santa Cruz Biotechnology sc-260-G), or rabbit anti-ERK1 NP-40 and then resuspended in 25 ml of the same buffer without NP-40. Protein kinase solution assays were conducted as described
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above using either 0.5 mg/ml myelin basic protein (ERK1/2) or histone H1 (cdk2, cyclin E).
Protein kinase gel assays (cdk4 and cyclin D1) were conducted Cell lines and culture. NIH 3T3 mouse embryo fibroblasts (ATCC using 5 ml of the immunocomplex in a total volume of 10 ml. Final CRL 1658) were used in these studies. Fibroblasts were cultured concentrations of components were 30 mM Hepes, pH 7. [50] , dried, and then exposed to X-OMAT film stock solution into DMEM/serum. Cells were treated between 28 and (Kodak, Rochester, NY) at 070ЊC for 24 h. Incorporation of phosphate 48 h. To reverse the KN-93 treatment, the medium was aspirated, was quantitated by scintillation counting of excised bands. GST-Rb rinsed once with DMEM/serum, and then replenished with DMEM/ represents a fusion protein of amino acids 379-928 of human pRb serum lacking with glutathione S-transferase obtained from Drs. Mark Ewen and Whole-cell lysate preparation. In order to examine enzymatic acJames DeCaprio, Dana Farber Cancer Center, Boston, Massachutivities, immunoreactive polypeptides, and nucleotide-binding prosetts [51] . GST-Rb expression is induced in the Bl-1 strain of Escheteins, cells were harvested with trypsin-EDTA and then rinsed cenrichia coli from the pGEX vector with 0.2 mM IPTG (Pharmacia, trifugally (2000g for 5 min) with PBS (phosphate-buffered saline) Piscataway, NJ). Cells were sonicated and centrifuged, and the sucontaining 2.6 mM EGTA. Pellets were resuspended in 3 vol of hopernatant was adsorbed to glutathione-Sepharose, washed with mogenization buffer, which consisted of 20 mM Hepes, pH 7.4, 2.6 PBS, and eluted with 10 mM glutathione as described [52] . mM EGTA, 20 mM MgCl 2 , 80 mM b-glycerol phosphate, 50 mM NaF, 0.1 mM okadaic acid (GIBCO-BRL), 0.1 mM dithiothreitol (DTT) 0.01
Immunoblots. Approximately 20 mg of sonicated whole-cell lysate from NIH 3T3 cells was separated on a 6 or 10% polyacrylamide gel mg/ml each chymostatin, leupeptin, aprotinin, pepstatin, and soybean trypsin inhibitor (Sigma, St. Louis, MO). Samples were then using the Mini-Protean gel electrophoresis system (Bio-Rad, Richmond, CA). Proteins were then transferred to 0.2-mm nitrocellulose sonicated (two 5-s bursts on ice), centrifuged at 10,000g for 15 min at 4ЊC, and either assayed immediately or stored at 070ЊC. Lysates sheets (Schleicher and Schuel, Keene, NH) for 1 h at 100 V and blocked with Tris-buffered saline, pH 7.4, 0.1% Tween 20 (TBST) containing 2.5% nonfat dry milk, 2.5% bovine serum albumin, and 2% normal goat serum for 1 h. The following purified antibodies were diluted to 0.5 mg/ml in 2% BSA/TBST/2% normal goat serum and incubated between 2 and 12 h with the nitrocellulose blot. Antibodies used included mouse anti-pRb (Pharmingen 14001A, San Diego, CA); rabbit anti-cyclin A (Santa Cruz Biotechnology sc-596), mouse anticyclin D1 (Santa Cruz Biotechnology sc-246); rabbit anti-cyclin E (Santa Cruz Biotechnology sc-481); rabbit anti-cdk2 (Santa Cruz Biotechnology sc-163); goat anti-cdk4 (Santa Cruz Biotechnology sc-260-G); rabbit anti-ERK1 and 2 (Santa Cruz Biotechnology sc-093); mouse anti-p27 kip1 (Transduction Labs, Lexington, KY, K25020); rabbit anti-p21 cip1 (Santa Cruz Biotechnology sc-756); goat anti-CaMK-I (Santa Cruz Biotechnology sc-1543); and goat anti-CaMK-IV (Santa Cruz Biotechnology sc-1546). After primary antibody incubations, blots were washed five times with TBST and then incubated for 2 h with 0.5 mg/ml goat or rabbit anti-mouse, anti-rabbit, or anti-goat IgG coupled to alkaline phosphatase (Kierkegaard Perry Labs, Gaithersburg, MD) in 2% BSA/TBST. Blots were washed five times with TBST and then developed with 0.25 mg/ml 5-bromo-4-chloro-3-indolyl phosphate and 0.25 mg/ml nitro blue tetrazolium (Sigma) in 0. 15 mM followed by a 20-h KN-93 washout (Reversal). The ing reactions were conducted with 5 mg protein from whole cell ly-same whole-cell lysates were processed as described under Materials sates, prepared as described above, and 0.5 nM (15 fmol in 30 ml) and Methods for both assays shown here. (A) 0.5-1 mg of protein freshly labeled CRE (5-AGA GAT TGC CTG ACG TCA GAG AGC was assayed in triplicate for Ca 2/ /CaM-dependent and independent TAG-3 ) or SRE (5-GGA TGT CCA TAT TAG GAC ATC T-3) oligo-activity and the percentage autonomy was calculated and plotted nucleotide. Oligonucleotide probes were 32 P-labeled using T4 poly-along with the percentage of cells that were not arrested in G1 phase. nucleotide kinase (New England BioLabs, Beverly, MA) and [g-32 P]-(B) 20 mg of protein from sonicated whole cells was then resolved ATP and then purified using Sepharose G-25 spin columns. The by SDS-PAGE and transferred to nitrocellulose. Immunoblots were binding reaction was conducted for 20 min at 25ЊC in 10 mM Tris, then conducted with an antibody against pRb. pH 7.5, 50 mM NaCl, 1 mM MgCl 2 , 0.5 mM EDTA, 0.5 mM DTT, 0.5 mg/ml poly(dI-dC), and 4% glycerol. DNA -protein complexes were resolved from free oligonucleotide by electrophoresis through dogenous CaMK-II stimulation can be detected since 4% nondenaturing polyacrylamide gels in 45 mM Tris-borate, 1 mM EDTA. Gels were then dried and imaged using a Kodak Phosphor-CaMK-II becomes autophosphorylated, displacing the Imager. Control competition reactions used an additional 50 nM autoinhibitory arm of CaMK-II and increasing the level (Fig. 1A) . Ca 2/ -dependent and -independent acid (TCA). DNA was collected on Whatman GF/C filter papers, rinsed five times with 5% TCA, and rinsed once with 95% ethanol, CaMK-II activities were proportional to the cellular and 3 H was detected by liquid scintillation spectrometry.
protein concentration within the range of 0.02 to 0.10 mg/ml. This activity inhibition paralleled the accumulation of cells in G1 phase [3] , achieving a maximum RESULTS effect between 10 and 15 mM. This detection of autonomous CaMK-II activity, which is dependent upon autoCaMK-II Autonomy Is Reversibly Decreased phosphorylation, in whole-cell extracts required the adin KN-93-Treated Cells dition of okadaic acid, a potent phosphatase inhibitor, in the dilution and assay buffers (see Materials and Previously, it was demonstrated that the CaM-dependent kinase inhibitory compound KN-93, which Methods). Twenty hours after KN-93 washout, CaMK-II autonomy had increased to serum-stimulated levels acts by antagonizing CaM binding, reversibly arrests rodent and human cells in G1 phase [2, 3] . Although it and cells had exited G1 phase and proceeded back into the cell cycle (Fig. 1A) . This inhibition of CaMK-II auwas demonstrated that CaMK-II was plentiful in these cells and that KN-93 added to CaMK-II assays in vitro tonomy in situ by externally applied KN-93 has been observed in other cell types [53] . Although KN-93 may blocked Ca 2/ /CaM-dependent activity, those studies did not demonstrate that endogenous CaMK-II stimu-inhibit other CaM-dependent kinases to achieve these results, we could not detect CaMK-I or CaMK-IV using lation was inhibited by externally applied 
pRb Phosphorylation Is Inhibited by KN-93
It is not known how CaMK-II inhibition by KN-93 results in G1 phase arrest. It is well known, however, that the product of the retinoblastoma (Rb) tumor-suppressor gene (pRb) is a protein of 110 kDa which is heavily phosphorylated by cdks as a necessary step for G1 phase progression in fibroblasts [54] . The endogenous level of pRb phosphorylation was examined by molecular weight shift on immunoblots in cells treated with KN-93. Slowly migrating pRb is phosphorylated and associated with cell cycle progression, whereas pRb of lower M r is less phosphorylated and associated with cell growth arrest [55] .
In exponentially growing NIH 3T3 cells, pRb is detected primarily as two high-molecular-weight bands around 115,000 M r (Fig. 1B, lane 1 However, p42 MAP kinase and p44 MAP kinase were not in- [46] . Measurement of the activity of immunopurified hibited when their activity was measured in immunocdks from cells treated with KN-93 could detect such precipitates from the same lysates in which cdk activalterations.
ities were decreased ( Fig. 2A, ERK1 /2). When cdk2 and cdk4 activities were assayed in vitro after immunoprecipitation using anti-cdk2, anti-cdk4, anti-cyclin D1, or anti-cyclin E antibodies from cells KN-93 Does Not Influence CREB or SRF treated with KN-93 for 48 h, both cdk2 and cdk4 activiin NIH 3T3 Cells ties were decreased at the same concentrations and to extents similar to the inhibition of pRb phosphorylation CaMKs are known to phosphorylate transcription factors, such as CREB and SRF (serum response fac- (Fig. 2) . The inhibition of these cdks was also reversible; 20 h after KN-93 washout, cells had reentered tor), to positively or negatively influence the transcription of their target genes. The influence of KN-93 on the cell cycle and cdk2 and cdk4 activities had both increased back toward control levels. KN-93 did not CREB and SRF function in NIH 3T3 cells was inferred from ''gel shift'' DNA-binding assays and through the directly inhibit cdk activity as demonstrated by incubating cdk2, immunopurified from untreated cells, with use of an antibody which recognizes the phosphorylation of CREB at Ser 133 [37] . increasing concentrations of KN-93 (data not shown).
There are reports which suggest that CaMK-II may When lysates from cells were incubated with oligonucleotides corresponding to consensus binding seoperate at times soon after mitogen stimulation of cells [58] . The mitogen-activated protein kinases quences for CREB and SRF, no significant change in the pattern of radioactive bands was observed in exp42 MAP kinase (ERK2) and p44 MAP kinase (ERK1) are signaling kinases which are activated within 30 min tracts taken from cells treated with and without KN- (Fig. 4) , consistent with the absence with antibodies against phospho-CREB.
of an effect on MAP kinase activity (Fig. 2) .
When cyclin levels were examined under these condi-93 ( Fig. 3) . A 100-fold excess of unlabeled competitive tions, cyclin D1, but not cyclin A, was reversibly altered (C) CRE or SRE oligonucleotide or noncompetitive (NC) in parallel with pRB phosphorylation and cdk activity AP1 oligonucleotide was used to confirm that the more (Fig. 5) . Cyclin D1 was decreased by 75% (lane 4) and slowly migrating bands were those specifically attrib-recovered to 58% of control (lane 5) after KN-93 washuted to CRE-protein and SRE-protein complexes out. Cyclin E migrates as a triplet of bands between (dashes). In two separate experiments, the level of spe-50 and 55 kDa, the slowest of which is believed to be cific bands did not significantly change relative to one a phosphoprotein [61, 62] . This slowest band (p55) was another. Antibodies to phosphorylated CREB (P-diminished to 40% of control upon KN-93 treatment CREB) also did not detect any change in the level of (lane 4) and returned to 60% of control upon washout two major polypeptides of approximately 42 and 40 kDa (lane 5). after KN-93 treatment (Fig. 3) . p27 kip1 Association with cdk2 Is Enhanced Cyclin D1 Levels Are Reversibly Decreased by during G1 Arrest The inhibition of cdk activity could be the result of When whole-cell lysates were screened for the cdk decreased cdk stimulatory phosphorylations, decreased inhibitor, p27 kip1 , by immunoblot, two protein bands of cyclin mass, increased inhibitory cdk phosphorylations, around 27 kDa were observed and did not change in or increased association of cdk inhibitors with cdks. mass as a result of KN-93 treatment or washout (Fig.  G1 cyclins in fibroblasts include A-and E-type cyclins, 6). Also, the levels of the cdk inhibitor p21 cip1 were which associate with cdk2, and cyclin D1, which associ-not induced in arrested cells (data not shown). The ates with cdk4 [60, 61] . The same whole-cell lysates subcellular distribution of p27 kip1 , however, varied unwhich showed cdk activity inhibition and pRb hypophosphorylation were first examined by immunoblot for levels of cdks (Fig. 4) . Cdk2 and cdk4 levels were mg of protein was then separated by SDS-PAGE and transferred to for 48 h and processed as described under Materials and Methods. 10 mg of protein from sonicated and centrifuged cells was then sepa-nitrocellulose (whole cell). 30 mg of protein was immunoprecipitated with anti-cdk2 and anti-cyclin E antibodies, separated by SDSrated by SDS -PAGE and transferred to nitrocellulose. Immunoblots were then conducted with antibodies against cdk2, cdk4, PAGE, and transferred to nitrocellulose. The immunoblot was then conducted with antibodies against p27 kip1 . and ERK1/2. G1 phase cell cycle arrest occurring in mid-G1 phase well before the initiation of DNA synthesis.
DISCUSSION
The results presented in this study suggest that CaMK-II mediates Ca 2/ /CaM-dependent G1 phase progression in mammalian fibroblasts by influencing cyclin D1 levels. This conclusion comes from findings that the inhibition of endogenous cellular CaMK-II by the CaM-binding antagonist KN-93 completely prevents DNA synthesis and leads to decreased levels of cyclin D1, a critical regulatory molecule of the G1 phase  FIG. 7 We believe that KN-93 is operating through CaMK-II in these cells for the following reasons: (i) CaMK-II autophosphorylation is inhibited in situ (Fig. 1) by the same concentrations which influence cell cycle moleder these conditions. In the absence of KN-93, very cules (Figs. 1, 2 , and 5); (ii) other CaMKs which could little p27 kip1 associated with cdk2 (CDK2 IP) or cyclin be inhibited by KN-93 were undetectable in these cells; E immunoprecipitates (cyclin E IP). Upon cell cycle (iii) the inactive KN-93 analog, KN-92, has no effect on arrest with 15 mM KN-93, the level of p27 kip1 associated the cell cycle or on the cell cycle molecules measured with cdk2 or cyclin E increased dramatically ( Fig. 6 , here; and (iv) the effects of KN-93 were reversible. We lane 2). After KN-93 washout, the level of p27 kip1 associ-cannot, however, definitively rule out the possibility ated with cdk2 or cyclin E decreased to control levels. that other CaMKs, such as CaMK-I, exist in these cells and mediate the cell cycle events which are inhibited
Cell Cycle Kinetics of Release from KN-93-Induced
by KN-93. Studies need to be conducted to define the G1 Arrest existence and/or role of CaMK-I in cell cycle progression in fibroblasts. Previously, it was demonstrated that NIH 3T3 and HeLa cells were arrested in the G1 phase of the cell Previous findings have used KN-93 and KN-62, another CaMK-II inhibitory compound, to support a role cycle by the CaMK inhibitor, KN-93 [2, 3] . G1 phase cell cycle arrest is also induced in human and mouse for CaMK-II in the progression of mammalian cells through G1 phase [2] [3] [4] , but have not demonstrated fibroblasts by Ca 2/ deprivation [9, 63] and release from G1 arrest caused by Ca 2/ deprivation results in S phase whether CaMK-II influences key cell cycle molecules.
Although there are multiple lines of evidence which entry after approximately 15 h [7] . Other studies have suggested that CaMK-II inhibition by KN-62 results in support a role for Ca 2/ , CaM, and CaMK-II in G1 phase progression (see Introduction), a clear demonstration the arrest of cells in both G1 and S phase [1, 4] . We therefore determined the level of DNA synthesis in of a link between CaMK-II inhibition and a block of cell cycle molecules has been lacking. cells treated with KN-93 and the kinetics of S phase entry after release from CaMK-II inhibition. The re-KN-93 can dissipate proton gradients in acid-secreting gastric cells, but at concentrations which do not sults shown here (Fig. 7A) indicated that DNA synthesis was blocked by over 95% when cells were treated influence the cell cycle [64] . KN-93 has also been reported to inhibit the activation of tyrosine hydroxylase, for 48 h with , that inhibition occurred half-maximally between 5 and 10 mM, and that recovery of DNA but this effect is mimicked by the inactive analog, . In this study, the exact same concentrations synthesis occurred after drug washout. These results confirm those previously reported using flow cytometry of KN-93 that block the stimulation of autonomous endogenous CaMK-II activity (the most accurate re- [2, 3] . These results also indicated that cells entered S phase approximately 15 h after the release from CaMK flection of intracellular CaMK-II stimulation) block the phosphorylation of the retinoblastoma protein pRb and inhibition (Fig. 7B) . These results are consistent with decrease the level of cyclin D1 and the activities of tion [79] caused by the decreased cdk2/cyclin E activity effected by p27 kip1 association or whether it reflects decdk2 and cdk4. KN-92 was completely ineffective in influencing the cell cycle [3] . All of these effects were creased activity of another kinase, such as CaMK-II. However, we were not able to phosphorylate immunoreversible and resulted in the resumption of DNA synthesis with kinetics consistent with a genuine mid-G1 purified cyclin E with partially purified CaMK-II (data not shown). There are two known cyclin E phosphorylaphase block.
The results presented here are consistent with a cy-tions-one accomplished by cdk2 and associated with degradation and the other associated with proliferating tosolic locus of action of CaMK-II on cyclin D1 levels. In a previous study, no nuclear targeted CaMK-II cells and an unknown kinase [61, 80] . mRNA was detected in NIH 3T3 cells [24] . In fact, in Cyclin A does not seem to be influenced at all by almost a dozen nondifferentiated cell types examined, CaMK-II inhibition in NIH 3T3 cells, even though the not a single nuclear targeted CaMK-II cDNA was re-cyclin A promoter contains a critical ATF1/CREB proported [21, 23, 24, [66] [67] [68] [69] [70] . In addition, KN-93 had no moter site which is necessary late in G1 [81] . ATF1 effect on transcription factors which would have been has been shown to be positively regulated by CaMK-I most likely influenced by nuclear targeted CaMK-II. and IV, but CaMK-II may not be as effective in vivo There is growing evidence that positive effects of [41, 43] . CaMKs on gene expression in certain cell types are Transient elevations of Ca 2/ occur during G1 phase mediated primarily by CaMK-I and CaMK-IV, two and may reflect the normal checkpoints through which other CaMKs which are undetectable in fibroblasts, but a cell passes in monitoring its extracellular environwhich are accessible to the nucleus [39] [40] [41] 44] . ment, its interaction with its cellular neighbors, and CaMK-II could regulate cyclin D1 levels through the its adherence to the substrate [11] . Cyclin D1 is bestimulatory phosphorylation of cytoplasmic molecules, lieved to respond to and integrate some of these signals which then enter the nucleus and positively influence with the cell cycle machinery, in contrast to cyclin E cyclin D1 transcription or translation. Inducible sites [73] . For example, in NIH 3T3 cells, the expression on the cyclin D1 promoter have been identified and of cyclin D1 is dependent on adhesion of cells to the include a CRE [71] . This is not a likely target of CaMK-substratum [77] and integrin-mediated adhesion of II since we have shown that CRE-binding proteins are cells via extracellular matrix binding requires trannot altered under conditions which decrease cyclin D1 sient elevations of Ca 2/ [82] . protein levels. Alternatively, CaMK-II phosphoryla-
The results presented here suggest that CaMK-II tions could block cyclin D1 degradation and thus in-may be the molecule which transduces these mid-to crease the half-life of this otherwise unstable regula-late G1 Ca 2/ signals from the cell surface to the cell tory protein [56, [72] [73] [74] . CaMK-II could phosphorylate cycle machinery. There are at least four different isocyclin D1 directly or it could phosphorylate molecules zymes of CaMK-II expressed in these cells [24] ; it rewhich antagonize ubiquitin-mediated cyclin D1 prote-mains to be determined which isozyme(s) is involved olysis [75] . Both transcriptional and proteolytic regula-in this pathway. Transmission of this signal could be tion of cyclins have previously been shown to be regu-accomplished by the phosphorylation by CaMK-II of lated by phosphorylation [46] .
proteins that induce the expression of cyclin D1 or that While cdk4 activity losses are the result of decreased stabilize cyclin D1 and therefore enhance cdk activity. cyclin D1 levels, cdk2 inhibition is most likely a result Cells which do not exhibit these transient elevations of the redistribution of p27 kip1 to cdk2, as previously of Ca 2/ as a result of contact inhibition or loss of anchorobserved in fibroblasts arrested in G1 phase by lovas-age would not be able to sustain CaMK-II activity and tatin [76] or by contact inhibition [77] . There are sig-thus cyclin levels, leading to cell cycle arrest. Transnificant levels of p27 kip1 in normally cycling cells which formed cells which no longer are influenced by contact associate with cdk2 and cdk4, but do not reach inhibi-inhibition may have lost the Ca 2/ -dependent regulation tory levels. A loss of cdk4/cyclinD1 causes a shift in of cyclin levels, but it remains to be determined exactly this balance so that the p27 kip1 level exceeds the re-how this step in the pathway is compromised. maining level of cdk/cyclins [76] . Lovastatin, like KN-93, causes a loss of cyclin D1, but not cyclin A or E, a redistribution of p27 kip1 to cdk2, and a 15-h recovery The amount of the slowest migrating cyclin E poly-viding the GST-Rb expression vector, to Dr. Carmen Sato-Bigbee peptide, a candidate phosphoprotein, was also revers-for the phospho-CREB antibody, and to Drs. Steven Grant, Eric ibly diminished by CaMK-II inhibition. It is not known Westin, Richard Moran, and Shirley Taylor for sharing laboratory equipment.
whether this reflects decreased cyclin E phosphoryla-
